Annual report [Section 13 and 15(d), not S-K Item 405]

SCHEDULE OF DEFERRED TAX ASSETS (Details)

v3.25.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Net operating losses $ 25,430,000 $ 20,861,000
Stock-based compensation 1,899,000 3,035,000
Interest expense 381,000 179,000
Accounts receivable reserve 129,000 121,000
Contributions carryover 242,000 285,000
Research and development credits 839,000
Intangibles (8,307,000) (8,358,000)
Inventory 684,000  
Inventory   (361,000)
Research and development costs 57,000 27,000
Total deferred tax assets: 20,515,000 16,628,000
Less valuation allowance (20,515,000) (16,628,000)
Net deferred tax assets (liabilities)